COMPANY
Sanguina, LLC
Funding and NIH signals
- NIH award NIH awarded $962K (SBIR Phase II 5R44HL139250-06, continuation, notice Jul 6, 2026). NIH RePORTER 5R44HL139250-06 (Jul 6, 2026)
Evidence (1 event)
- Jul 6, 2026 · NIH RePORTER 5R44HL139250-06
Organization: SANGUINA, LLC; City/State: ATLANTA, GA; Project number: 5R44HL139250-06; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-06; FY total cost (award amount): 962375; Administering IC: National Heart Lung and Blood Institute; Project title: Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients; Organization type: Domestic For-Profits
- Jul 6, 2026 · NIH RePORTER 5R44HL139250-06